Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on: June 01,2024 5

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on:June 01,2024 5

Race, income can determine blood cancer outcomes, studies show

by Ernie MundellIf someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.The ongoing impact of patien

Updated on: January 22,2024 15

Race, income can determine blood cancer outcomes, studies show

by Ernie MundellIf someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.The ongoing impact of patien

Updated on:January 22,2024 15

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Updated on: September 27,2024 0

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Updated on:September 27,2024 0

Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

by Weill Cornell Medical CollegeMycobacterium tuberculosis. Credit: United States Centers for Disease Control and PreventionPatients who have drug-resistant tuberculosis (TB) have a similar micro

Updated on: May 26,2024 8

Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

by Weill Cornell Medical CollegeMycobacterium tuberculosis. Credit: United States Centers for Disease Control and PreventionPatients who have drug-resistant tuberculosis (TB) have a similar micro

Updated on:May 26,2024 8

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha

Updated on: January 10,2024 8

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha

Updated on:January 10,2024 8

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on: January 07,2024 25

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on:January 07,2024 25

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on: March 30,2024 0

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on:March 30,2024 0

3D genome features point to possible therapeutic target for aggressive and deadly pediatric brain tumors

by Fabienne Landry,McGill University Health CentreCredit:Cell(2024). DOI: 10.1016/j.cell.2024.06.023Posterior fossa group A (PFA) ependymoma are rare, treatment-resistant pediatric t

Updated on: July 11,2024 0

3D genome features point to possible therapeutic target for aggressive and deadly pediatric brain tumors

by Fabienne Landry,McGill University Health CentreCredit:Cell(2024). DOI: 10.1016/j.cell.2024.06.023Posterior fossa group A (PFA) ependymoma are rare, treatment-resistant pediatric t

Updated on:July 11,2024 0

Cancer cases will keep rising worldwide: Report

by Dennis ThompsonCancer cases will continue to climb for the next two decades, spurred on by an aging worldwide population, a new report shows.An estimated 20 million new cancer cases were diagnosed

Updated on: April 06,2024 0

Cancer cases will keep rising worldwide: Report

by Dennis ThompsonCancer cases will continue to climb for the next two decades, spurred on by an aging worldwide population, a new report shows.An estimated 20 million new cancer cases were diagnosed

Updated on:April 06,2024 0

Trends and hotspots in lung cancer surgery research reviewed over the last decade

by Health Data ScienceTrends of (a) annual scholarly outputs and (b) average field citation ratios in the world and top five countries in the field of lung cancer surgery, 2012-2021, and association b

Updated on: December 25,2023 8

Trends and hotspots in lung cancer surgery research reviewed over the last decade

by Health Data ScienceTrends of (a) annual scholarly outputs and (b) average field citation ratios in the world and top five countries in the field of lung cancer surgery, 2012-2021, and association b

Updated on:December 25,2023 8

Study reveals why testicular cancer is so responsive to chemo

by Cornell UniversityA low magnification image of a germ cell tumor, called a teratocarcinoma, from a new mouse model developed to study testicular cancer. A cluster of cancer stem cells, termed

Updated on: July 02,2024 3

Study reveals why testicular cancer is so responsive to chemo

by Cornell UniversityA low magnification image of a germ cell tumor, called a teratocarcinoma, from a new mouse model developed to study testicular cancer. A cluster of cancer stem cells, termed

Updated on:July 02,2024 3

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on: May 26,2024 3

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on:May 26,2024 3